Alseres Pharmaceuticals Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 |
| Cost of Goods Sold | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 18.8 | 26.3 | 11.4 |
| Depreciation & Amortization | 0.1 | 0.2 | 0.2 |
| Operating Income | (18.9) | (26.4) | (11.6) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 0.2 | 0.2 | 0.2 |
| Nonoperating Expenses | 0.9 | 0.1 | 0.1 |
| Income Before Taxes | (19.5) | (26.4) | (11.5) |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | (19.5) | (26.4) | (11.5) |
| Continuing Operations | (19.5) | (26.4) | (11.5) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (19.5) | (26.4) | (11.5) |
| Total Net Income | (19.5) | (26.4) | (11.5) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (1.04) | (1.59) | (1.03) |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
